Andrea Morrione graduated in Biochemistry at Universita’ degli Studi di Milano, Milan, Italy. In 1997, he joined the Faculty of Thomas Jefferson University at the Department of Microbiology. In 2002, after receiving an NIH/NIDDK Career Development Award, he joined the Department of Urology at Jefferson, where he served as the Director for Urology Basic Science and Associate Professor. He has now joined the Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, where he is currently an Associate Professor (Research) and Director of the Molecular Mechanisms of Cancer Signal Transduction Program. He serves as a member of numerous editorial boards of high-impact factor journals, including matrix biology, cancers, and frontiers in endocrinology (Cancer Endocrinology). In recent years, he built an NIH-funded program in the investigation of growth factor signaling (progranulin) in bladder cancer. As an expert in cancer cell signaling, he has served on several organizing committees, chaired sessions, and presented his work at numerous international meetings. He has acted as an expert reviewer on Study Sections for the NIH, American Urological Association (AUA) and BCAN (Bladder Cancer Advocacy Network), and serves as an expert reviewer for numerous funding agencies including The Research Grants Council (RGC) of Hong Kong, AIRC (Associazione Italiana Ricerca sul Cancro), Breast Cancer Campaign, Genome British Columbia and Diabetes, UK.